Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

DK Interferon alpha -10

Next Previous
X
Search
Drug Profile

DK Interferon alpha -10

Alternative Names: DKIFN-α10 DKIFN-α10

Latest Information Update: 16 Oct 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Deka Biosciences
  • Class Antineoplastics; Immunoglobulin Fv fragments; Immunotherapies; Interferons; Interleukins; Recombinant fusion proteins
  • Mechanism of Action Interferon alpha replacements; Interleukin 10 replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Bladder cancer; Colorectal cancer; Head and neck cancer; Lung cancer; Pancreatic cancer; Renal cancer; Skin cancer

Most Recent Events

  • 25 Sep 2023 DK Interferon alpha -10 DK IFN alpha -10 is available for licensing as of 25 Sep 2023. https://www.dekabiosciences.com/our-science/ (Deka Biosciences pipeline, September 2023)
  • 18 Sep 2023 Preclinical trials in Bladder cancer in USA (SC), prior to September 2023 (Deka Biosciences pipeline, September 2023)
  • 18 Sep 2023 Preclinical trials in Colorectal cancer in USA (SC), prior to September 2023 (Deka Biosciences pipeline, September 2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top